EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Five‐Year Clinical Outcomes Following Nephrectomy for Renal Cell Carcinoma: Evidence From a Nationwide Japanese Surgical Registry

Ryuichi Mizuno, Kyoko Yamamoto, Hiroyuki Yamamoto, Shingo Hatakeyama, Shinichi Sakamoto, Takahiro Yasui, Takashi Kobayashi, Toshiyuki Kamoto, Eiji Kikuchi, Akihiro Ito, Haruki Kume

International Journal of Urology · 2026-11 · 33 (11)

DOI: 10.1111/iju.70695 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Objectives To characterize mid‐term oncological outcomes after nephrectomy for renal cell carcinoma (RCC) in Japan using the National Clinical Database (NCD). Methods We retrospectively analyzed patients with RCC who underwent nephrectomy between April and December 2018 and had at least 5 years of follow‐up recorded in the NCD. Age, sex, nephrectomy type, operative approach, and pathological T category were evaluated. Disease‐free survival (DFS) and overall survival (OS) were estimated using the Kaplan–Meier method and compared with the log‐rank test. Results Of 16 786 patients registered at 759 institutions, 9065 with available 5‐year follow‐up were analyzed. Patients aged ≥ 75 years comprised 24.7% of the cohort. Radical and partial nephrectomy were performed in 55.0% and 45.0% of patients, respectively. Median DFS and OS were not reached. Older age and male sex were associated with shorter DFS and OS. Radical nephrectomy and open surgery were also associated with shorter survival. Both DFS and OS decreased significantly with advancing pathological stage, with earlier recurrence in pT3–4 disease. Conclusions This nationwide NCD‐based study provides descriptive mid‐term survival data for patients with RCC undergoing nephrectomy in Japan. Age, sex, nephrectomy type, operative approach, and pathological stage were associated with survival differences. These findings provide real‐world outcome data for patients with available long‐term follow‐up and a basis for future risk‐adjusted analyses.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →